Kendle is among the world's leading global clinical research organisations. The company is the fourth-largest provider of Phase II-IV clinical development services worldwide. It has conducted clinical trials and provided regulatory and pharma-covigilance services in more than 80 countries.

Kendle's Scottish operations include a range of Phase II-IV services, including global Clinical Development, Regulatory Affairs, Biometrics and Late Phase offerings.

Kendle currently occupies 40% of the Fleming Building.

For more information please visit www.kendle.com/

COPYRIGHT | LEGAL | PRIVACY POLICY